SourceName: plasma samples  
SourceName: blood plasma sample  
SampleTreatment: denatured, reduced, alkylated, and digested  
ReductionReagent: SDC reduction and alkylation buffer  
AlkylationReagent: SDC reduction and alkylation buffer  
CleavageAgent: trypsin/LysC mix  
ConcentrationOfCompound: 0.05 (μg/μl)  
Temperature: 4°C  
Temperature: 95°C  
Time: 10 min  
Time: 5 min  
Temperature: room temperature  
Temperature: 37°C  
Time: 4 h  
Time: 15 min  
Instrument: EASY‐nLC 1200 system  
IonizationType: nano‐electrospray ion source  
Instrument: Q Exactive HF Orbitrap  
Separation: Purified peptides were separated on 40‐cm HPLC columns (ID: 75 μm; in‐house packed into the tip with ReproSil‐Pur C18‐AQ 1.9 μm resin (Dr. Maisch GmbH))  
AssayName: LC‐MS/MS analysis  
GradientTime: 45‐min gradients  
PooledSample: pooled samples from all healthy individuals, NAFLD patients, and liver cirrhosis patients separately  
Depletion: serial depletion with a top6 (Multiple Affinity Removal Column Human 6; Agilent) and top14 depletion kits (Seppro Protein Depletion; Sigma‐Aldrich)  
Separation: separated by the Spider Fractionator (Kulak et al, 2017)  
NumberOfFractions: 24 fractions  
GradientTime: linear 35‐min gradient of 3–30% of buffer B (0.1% formic acid, 5% DMSO, 80% (v/v) acetonitrile)  
GradientTime: 7‐min increase to 75% of buffer B  
GradientTime: 1‐min increase to 98% of buffer B  
GradientTime: 2‐min wash of 98% buffer B  
FlowRateChromatogram: 450 nl/min  
Temperature: 60°C  
AssayName: Top15 data‐dependent MS/MS scan method  
AssayName: BoxCar scan method  
FragmentationMethod: higher‐energy collisional dissociation (HCD)  
CollisionEnergy: normalized collision energy of 27 eV  
AssayName: data‐independent acquisition (DIA) method  
CollisionEnergy: Normalized stepped collision energy was set to 25, 27.5, 30  
Organism: C57Bl6/J mice  
Age: 8‐week‐old  
Sex: male  
Strain: C57Bl6/J mice  
Compound: GLP‐1/GIP co‐agonist  
Compound: GLP‐1  
Compound: GIP  
ConcentrationOfCompound: 10 nmol/kg  
Time: 15 days  
NumberOfSamples: 48  
Disease: NAFLD  
Disease: cirrhosis  
Disease: T2D  
NumberOfTechnicalReplicates: three technical replicates  
NumberOfMissedCleavages: 2  
Modification: cysteine carbamidomethylation  
Modification: oxidation on methionine  
Modification: N‐terminal acetylation